Deep Track Capital, LP Allakos Inc. Transaction History
Deep Track Capital, LP
- $3.03 Billion
- Q1 2024
A detailed history of Deep Track Capital, LP transactions in Allakos Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 5,000,000 shares of ALLK stock, worth $5 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
5,000,000
Previous 2,510,736
99.14%
Holding current value
$5 Million
Previous $6.85 Million
8.08%
% of portfolio
0.21%
Previous 0.26%
Shares
6 transactions
Others Institutions Holding ALLK
# of Institutions
104Shares Held
77.4MCall Options Held
70.7KPut Options Held
2.8K-
Bvf Inc San Francisco, CA16.6MShares$16.6 Million0.62% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$6.15 Million0.54% of portfolio
-
Black Rock Inc. New York, NY4.72MShares$4.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.79MShares$3.79 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA3.45MShares$3.45 Million0.17% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $84.7M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...